(NASDAQ:TVTX – Get Rating) – Analysts at Wedbush lowered their FY2022 earnings per share estimates for Travere Therapeutics in a research report issued to clients and investors on Monday, January 23rd. Chico now expects that the company will earn ($4.43) per share for the year, down from their prior About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features Press Copyright Contact us Creators. 0001143189.txt : 20140304 : 20140304 20140304151747 accession number: 0001143189 conformed submission type: 424b2 public document count: 7 filed as of date: 20140304 date as of change: 20140304 filer: company data: company conformed name: hsbc usa inc /md/ central index key: …Travere Therapeutics, Inc.
0 kommentar(er)
